After the official launch of the BeFlow earlier this week, Bentley has announced that it successfully launched two additional products at the Leipzig Interventional Course (LINC 2025; 28–30 January, Leipzig, Germany): the BeGraft stent graft system and the BeFlared fenestrated endovascular aneurysm repair (FEVAR) stent graft system.
The company notes that the BeGraft is the world’s first on-label bridging device, while the BeFlared is the first dedicated indicated bridging stent for FEVAR procedures.
“Launching three product news at the same time is the result of team effort and many years of development. In view of the new, comprehensive EU Medical Device Regulation, this is not only a special moment for us, but certainly also a highlight for endovascular specialists who perform these complex FEVAR procedures,” says Sebastian Büchert, chief executive officer of Bentley.
He continues: “We’re at the forefront of this market, offering solutions that fill a critical gap. The positive feedback and strong demand underscore the significant potential that we have prepared our infrastructure for.”
Bentley details that the BeFlared stent is crimped on a specially designed stepped balloon, which will reduce the number of steps that are needed for optimal deployment. Additionally, a third radiopaque marker aids in optimal positioning of the stents in the fenestration. The BeFlared is available in diameters from 5 to 9mm and in stent lengths of 22, 27 and 37mm. The flared diameter is 2 to 3mm larger compared to the native sizing of the stent.
The commercial market launch of BeFlared at LINC 2025 was accompanied by a presentation and live case at the meeting. Stéphan Haulon (Hôpital Marie Lannelongue, Paris, France), who is a scientific advisor for Bentley, shared his first experiences with the BeFlared and highlighted its various advantages in FEVAR procedures. Haulon also performed a live case in which he used the BeFlared stent.
“This dedicated bridging stent allows precise positioning and accurate deployment thanks to a third extra marker on the balloon catheter. The specially designed ‘stepped’ balloon will make sure that the stent can be inflated in one step (positioning and flaring). This is not only a gamechanger, but one of the most important milestones in the history of fenestrated aortic endografting,” says Haulon.
Before the official market launch of BeFlared, Bentley notes that more than 200 of the stents were used in patients suffering from complex aortic aneurysms. Twelve leading specialists who had the opportunity to use this new stent graft system reported excellent results regarding usability and initial clinical outcomes. Bentley shares that they agreed the BeFlared will make fenestrated endografting much simpler and swifter. “We are pleased that the first experiences with the device confirm a shorter overall time for procedural and fluoroscopy per target vessel,“ remarks Haulon.
Bentley advises that the BeFlared is now commercially available in line with country specific market regulations.
